B.S. in Pharmaceutical Science, Peking University, China
Ph.D. in Medicinal Chemistry, Peking University, China
Work Experience
2024-present
Assistant Investigator, Chinese Institutes for Medical Research, Beijing, China
2020-2024
Postdoctoral Fellow, College of Chemistry and Molecular Engineering, Peking University, China
2019-2020
Research Assistant, School of Pharmaceutical Science, Peking University, China
Research Direction
The Zhu laboratory at CIMR is dedicated to exploring the frontiers of biocompatible chemistry, genetic code expansion, and directed evolution, with the aim of enhancing drug discovery capacity and developing more effective therapies for human diseases by leveraging the insights and tools derived from our research.
Major Research Projects
1. Design, develop, and optimize new biocompatible reactions
2. Directed evolution of enzymes to enhance promiscuity
3. Peptide-based drug discovery based on Non-canonical display platform
Major Contributions
1. Developed one-step transformation of carboxylic acids and alcohols via oxygen-centered radicals to simplify the synthesis of drugs and bioactive molecules (Organic Letters, 2015; ACS Catalysis, 2016; Nature Communications, 2018; Angewandte Chemie, 2020).
2. Developed tryptophan (Nature Chemistry, 2024) and phenylalanine (in submission) decaging techniques, achieving functional regulation of various levels of biological interactions (peptide-peptide, peptide-protein, protein-protein, cell-cell) and potentially regulate over 28,000 proteins' functions in living cells.
3. Developed a broad-spectrum small molecule-responsive allosteric protein switch, revealing new phosphorylation sites related to mitochondrial tyrosine kinases, and studied their relationship with mitochondrial quality control (In preparation).
Zhu YC, Lin F, Liu ZQ, Wang X, Wang SB, Fan XY#, Chen PR#. Bioorthogonal Cleavage Chemistry: Harnessing the Bond-break Reactions for Biomolecule Manipulations in Living Systems. Chinese Journal of Chemistry 2024. DOI:10.1002/CJOC.202400876.R1